Craneware plc Dividend Currency Election

RNS Number : 0186I

Craneware plc

22 March 2024

 

Craneware plc

("Craneware" or the "Company" or the "Group")

Dividend Currency Election

22 March 2024 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its interim dividend announced on 4 March 2024.

For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.27.

 

For further information, please contact:

 

Craneware plc	[phone]
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications	[phone]
Caroline Forde, Kinvara Verdon	[e-mail]
Peel Hunt (NOMAD and Joint Broker)	[phone]
Neil Patel, Paul Gillam, Kate Bannatyne
Investec Bank PLC (Joint Broker)	[phone]
Patrick Robb, Cameron MacRitchie
Berenberg (Joint Broker)	[phone]
Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DIVJTMITMTBTBJI